Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training
HyperLa
HyperLa: Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance Training: A Multi-centre Study by the HyperLa Study Group
1 other identifier
interventional
120
4 countries
8
Brief Summary
The HyperLa study investigates whether a person's "glycolyticness"-the efficiency with which their body uses glycolysis for energy-can predict how much their muscles will grow (hypertrophy) in response to resistance training. Participants will undergo a specialized "vLapeak" test, which measures the maximal rate of lactate accumulation during a 10-second all-out cycling sprint, to determine their individual glycolytic power. Following this initial assessment, participants will complete eight weeks of standardized, twice-weekly resistance training focused on the lower body. The study aims to determine if individuals with higher initial vLapeak values experience greater increases in muscle size compared to those with lower values. This research may help explain why people respond differently to exercise and support the development of personalized training programs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy-volunteers
Started May 2026
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2026
CompletedFirst Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
July 23, 2026
June 1, 2026
7 months
June 25, 2026
July 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in mid-thigh Muscle Thickness
Change in mid-thigh muscle thickness (combination of rectus femoris and vastus intermedius) as measured by ultrasound.
Baseline and Week 8 (completion of training intervention)
Change in lateral-thigh Muscle Thickness
Change in lateral thigh muscle thickness (combination of vastus lateralis and vastus intermedius) as measured by ultrasound.
Baseline and Week 8 (completion of training intervention)
Secondary Outcomes (5)
Change in Peak Rate of Blood Lactate Accumulation (vLapeak)
Baseline and Week 8 (completion of training intervention)
Change in Vastus Lateralis Muscle Cross-Sectional Area (CSA)
Baseline and Week 8 (completion of training intervention)
Maximal Strength (3RM) for Leg Press
Baseline and Week 8 (completion of training intervention)
Maximal Strength (3RM) for Leg Exentsion
Baseline and Week 8 (completion of training intervention)
Change in Relative Abundance of Selected Plasma Metabolites
Baseline and Week 8 (completion of training intervention)
Study Arms (1)
Resistance Training Group
EXPERIMENTALParticipants in this single-arm cohort will undergo an 8-week standardized, hypertrophy-focused lower-body resistance training program.
Interventions
Standardized training consisting of twice-weekly supervised sessions for 8 weeks. Each session includes 4 sets of 8-12 repetitions of leg press (or Smith-machine squat) and leg extensions. Training intensity progresses from an RPE of 6 to voluntary muscular failure starting from week three.
Eligibility Criteria
You may qualify if:
- Body Mass Index (BMI) between 20-29 kg/m2
- No structured resistance training performed in the last twelve months.
- Maximum of four sessions per week of recreational or low-to-moderate aerobic endurance activity.
- No history of competitive strength or physique sports.
You may not qualify if:
- Diagnosed cardiovascular, pulmonary, metabolic, neuromuscular, or orthopaedic disease that contraindicates exercise.
- Positive response to any question on the PAR-Q 2025 questionnaire.
- Current use of anabolic steroids, creatine, or other substances known to strongly influence muscle hypertrophy.
- Regular engagement in shift work.
- Women who are pregnant or breastfeeding.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Technical University of Munichlead
- Chemnitz University of Technologycollaborator
- DLR German Aerospace Centercollaborator
- University of Jyvaskylacollaborator
- University of Limerickcollaborator
- IST University of Applied Sciences Düsseldorfcollaborator
- Institute for Applied Training Science (IAT/FES e.V.)collaborator
Study Sites (8)
University of Jyväskylä, Faculty of Sport and Health Sciences
Jyväskylä, Central Finland, 40014, Finland
Technical University of Munich, TUM School of Medicine and Health
München, Bavaria, 80809, Germany
DLR Cologne, Department of Metabolism and Human Performance
Cologne, North Rhine-Westphalia, 51147, Germany
iST University of Applied Sciences
Düsseldorf, North Rhine-Westphalia, 40233, Germany
TU Chemnitz, Sports Medicine and Exercise Therapy
Chemnitz, Saxony, 09126, Germany
Institute for Applied Training Science (IAT) Leipzig
Leipzig, Saxony, 04109, Germany
University of Limerick, Department of Physical Education and Sport Sciences (PESS)
Limerick, Limerick, V94 T9PX, Ireland
Universidad Politécnica de Madrid, Facultad de Ciencias de la Actividad Física y del Deporte (INEF)
Madrid, Madrid, 28040, Spain
Related Publications (4)
Ahtiainen JP, Walker S, Peltonen H, Holviala J, Sillanpaa E, Karavirta L, Sallinen J, Mikkola J, Valkeinen H, Mero A, Hulmi JJ, Hakkinen K. Heterogeneity in resistance training-induced muscle strength and mass responses in men and women of different ages. Age (Dordr). 2016 Feb;38(1):10. doi: 10.1007/s11357-015-9870-1. Epub 2016 Jan 15.
PMID: 26767377BACKGROUNDWackerhage H, Kabasakalis A, Seiler S, Heck H. Is the vLamax for Glycolysis What the V O 2 max is for Oxidative Phosphorylation? Sports Med. 2025 Aug;55(8):1853-1866. doi: 10.1007/s40279-025-02259-6. Epub 2025 Jul 17.
PMID: 40676393BACKGROUNDWackerhage H, Vechetti IJ, Baumert P, Gehlert S, Becker L, Jaspers RT, de Angelis MH. Does a Hypertrophying Muscle Fibre Reprogramme its Metabolism Similar to a Cancer Cell? Sports Med. 2022 Nov;52(11):2569-2578. doi: 10.1007/s40279-022-01676-1. Epub 2022 Apr 23.
PMID: 35460513BACKGROUNDWarburg O, Wind F, Negelein E. THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol. 1927 Mar 7;8(6):519-30. doi: 10.1085/jgp.8.6.519. No abstract available.
PMID: 19872213BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 23, 2026
Study Start
May 4, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
July 23, 2026
Record last verified: 2026-06